Compare FULC & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULC | REPX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 718.4M | 587.9M |
| IPO Year | 2019 | 2003 |
| Metric | FULC | REPX |
|---|---|---|
| Price | $7.57 | $33.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $16.38 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.1M | 354.4K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | N/A | ★ 78.17 |
| EPS | N/A | ★ 7.59 |
| Revenue | N/A | ★ $3,038,000.00 |
| Revenue This Year | N/A | $20.94 |
| Revenue Next Year | N/A | $11.13 |
| P/E Ratio | ★ N/A | $4.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.32 | $21.98 |
| 52 Week High | $15.74 | $34.32 |
| Indicator | FULC | REPX |
|---|---|---|
| Relative Strength Index (RSI) | 32.65 | 68.05 |
| Support Level | $7.40 | $26.51 |
| Resistance Level | $7.64 | N/A |
| Average True Range (ATR) | 0.64 | 1.30 |
| MACD | -0.10 | 0.40 |
| Stochastic Oscillator | 1.01 | 83.23 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.